Pharma BD Deal Intelligence
Bristol-Myers Squibb Company / Kosan Biosciences Incorporated
2008 · Acquisition/Merger · $190M · Complete
Announcement Sentiment
75
Strongly positive
$5.50/share cash tender; Hsp90 inhibitors, epothilones; closed June 26 2008
Key facts
- Announced May 29, 2008
- Closed Jun 26, 2008
- Deal value $190M
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals